Rubidium Fluoratum (Hahnemann Laboratories, Inc.)
Welcome to the PulseAid listing for the Rubidium Fluoratum drug offered from Hahnemann Laboratories, Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Hahnemann Laboratories, Inc. |
NON-PROPRIETARY NAME: | Rubidium Fluoratum |
SUBSTANCE NAME: | RUBIDIUM FLUORIDE |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | BUCCAL; ORAL; SUBLINGUAL |
DOSAGE FORM: | PELLET |
MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
START MARKETING DATE: | 2016-12-01 |
END MARKETING DATE: | 0000-00-00 |
Rubidium Fluoratum HUMAN OTC DRUG Details:
Item Description | Rubidium Fluoratum from Hahnemann Laboratories, Inc. |
LABELER NAME: | Hahnemann Laboratories, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 30([hp_C]/[hp_C]) |
START MARKETING DATE: | 2016-12-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 63545-673_44cfb486-a602-10ee-e054-00144ff8d46c |
PRODUCT NDC: | 63545-673 |
APPLICATION NUMBER: | |
Other RUBIDIUM FLUORIDE Pharmaceutical Manufacturers / Labelers: